Insider Transactions Reported by 18 Insiders of Sarepta Therapeutics, Inc.

Symbol
SRPT on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Sarepta Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard Barry Director $112,179,844 16 May 2025
Michael Andrew Chambers Director $29,507,710 18 Dec 2025
M. KATHLEEN BEHRENS Director $21,100,461 10 Mar 2025
DOUGLAS S. INGRAM Chief Executive Officer, Director $16,729,038 07 Dec 2025
Ian Michael Estepan Chief Operating Officer $6,368,948 -$294,202 -4.4% 16 Dec 2025
Louise Rodino-Klapac President, R&D and Tech Ops $6,183,057 17 Nov 2025
Dallan Murray Chief Customer Officer $5,881,591 07 Mar 2025
Bilal Arif Chief Tech Ops Officer $5,310,650 05 Aug 2025
Cristin Rothfuss EVP, General Counsel $2,951,646 28 Nov 2025
Ryan Ho-Yan Wong Chief Financial Officer $2,851,503 01 Dec 2025
Ryan Brown EVP, General Counsel $2,818,063 21 Jun 2024
Claude Nicaise Director $2,771,188 -$248,203 -8.2% 12 Mar 2025
Hans Wigzell Director $2,525,579 10 Mar 2025
William Ciambrone Evp $1,775,434 04 Mar 2022
MARY ANN GRAY Director $992,681 07 Mar 2022
Stephen Mayo Director $901,571 10 Mar 2025
Kathryn Jean Boor Director $827,374 10 Mar 2025
Deirdre P. Connelly Director $523,179 10 Mar 2025

Recent Insider Transactions by Companies or Individuals for Sarepta Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.